CHEST 2019

Complete Coverage

COPD

Using Electronic Health Records to Predict Mortality Post COPD Hospitalization

By

Sheila Jacobs

For COPD, can electronic health record data predict 90-day post hospitalization mortality — and thereby serve as a risk stratification tool?

CHEST 2019

Influenza Vaccinations Benefit Patients Hospitalized With Pneumonia

In-hospital influenza vaccination may lower costs and risk for readmission or death.

CHEST 2019

Sleep Apnea Linked to Increased Likelihood of Home Oxygen Therapy at Hospital Discharge

By

Pulmonology Advisor Contributing Writer

Patients with sleep apnea are 4 more likely to be prescribed home oxygen after hospital discharge than those without sleep apnea.

CHEST 2019

Use of FEV1/FEV6 Ratio May Lead to Underdiagnosis of COPD in Women

By

Pulmonology Advisor Contributing Writer

There is significant disparity in the ratios for postbronchodilator FEV1/FEV6 and FEV1/FVC %, and this disparity is very pronounced in women.

CHEST 2019

Preventive Moxifloxacin Well-Tolerated in People With Latent TB Exposed to MDR-TB

By

Natasha Priya Dyal, MD

Although uptake was limited, prophylactic treatment with moxifloxacin was well-tolerated in individuals with evidence of latent tuberculosis who were in contact with patients with high-risk multidrug-resistant tuberculosis.

CHEST 2019

Improved In-Hospital Mortality for Patients With Known OSA Admitted for MI

By

Utsav Aiya, MD

Patients admitted to the hospital for myocardial infarction with a known diagnosis of obstructive sleep apnea were found to have improved in-hospital mortality.

CHEST 2019

Home Oxygen Use Associated With Worsened Physical Function in COPD and IPF

By

Brandon May

Use of home oxygen is associated with reduced physical function in patients with either COPD or idiopathic pulmonary fibrosis.

CHEST 2019

Pulmonary Embolism With Tobacco Dependence Linked to 30-Day Readmission

By

Pulmonology Advisor Contributing Writer

Patients with tobacco dependence and pulmonary embolism are likely to be readmitted to the hospital within 30 days of initial discharge due to pulmonary embolism.

CHEST 2019

Gefapixant Improves Quality of Life and Cough Frequency in Chronic Cough

By

Pulmonology Advisor Contributing Writer

Gefapixant has demonstrated efficacy in improving objective cough frequency and quality of life among individuals with chronic cough.

CHEST 2019

Macitentan and Tadalafil Combination Improves PVR in Pulmonary Arterial Hypertension

By

Brandon May

Combination therapy consisting of once-daily macitentan and tadalafil was associated with reductions in pulmonary vascular resistance in patients with pulmonary arterial hypertension.